JavaScript is disabled for your browser. Some features of this site may not work without it.
Система будет остановлена для регулярного обслуживания. Пожалуйста, сохраните рабочие данные и выйдите из системы.
Statistics
Total Visits
| Views | |
|---|---|
| THE ZEB2-DEPENDENT EMT TRANSCRIPTIONAL PROGRAMME DRIVES THERAPY RESISTANCE BY ACTIVATING NUCLEOTIDE EXCISION REPAIR GENES ERCC1 AND ERCC4 IN COLORECTAL CANCER | 61 |
Total Visits Per Month
| January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | |
|---|---|---|---|---|---|---|---|
| THE ZEB2-DEPENDENT EMT TRANSCRIPTIONAL PROGRAMME DRIVES THERAPY RESISTANCE BY ACTIVATING NUCLEOTIDE EXCISION REPAIR GENES ERCC1 AND ERCC4 IN COLORECTAL CANCER | 1 | 2 | 1 | 6 | 0 | 6 | 0 |
File Visits
| Views | |
|---|---|
| Molecular Oncology - 2021 - Sreekumar - The ZEB2‐dependent EMT transcriptional programme drives therapy resistance by.pdf | 16 |
Top country views
| Views | |
|---|---|
| United States | 35 |
| Russia | 11 |
| China | 5 |
| Argentina | 1 |
| Netherlands | 1 |
| Portugal | 1 |
| Turkey | 1 |
| Ukraine | 1 |
Top cities views
| Views | |
|---|---|
| Oakland | 11 |
| Moscow | 9 |
| Boardman | 6 |
| Louisville | 6 |
| Menlo Park | 4 |
| Des Moines | 2 |
| Xiamen | 2 |
| Cebeci | 1 |
| Feira | 1 |
| Hangzhou | 1 |
Submission guide